Literature DB >> 25669213

Is the ``$1000 Genome'' really $1000? Understanding the full benefits and costs of genomic sequencing.

Kathryn A Phillips1, Mark J Pletcher2, Uri Ladabaum3.   

Abstract

Entities:  

Keywords:  Sequencing; cost-effectiveness; economics; price

Mesh：

Year:  2015        PMID： 25669213      PMCID： PMC4527943          DOI： 10.3233/THC-150900

Source DB:  PubMed          Journal:  Technol Health Care        ISSN： 0928-7329            Impact factor:   1.285


× No keyword cloud information.
  17 in total

Review 1.  Genomic medicine: a decade of successes, challenges, and opportunities.

Authors:  Jeanette J McCarthy; Howard L McLeod; Geoffrey S Ginsburg
Journal:  Sci Transl Med       Date:  2013-06-12       Impact factor: 17.956

2.  Economic incentives for evidence generation: promoting an efficient path to personalized medicine.

Authors:  Adrian Towse; Louis P Garrison
Journal:  Value Health       Date:  2013 Sep-Oct       Impact factor: 5.725

3.  Diagnostic clinical genome and exome sequencing.

Authors:  Leslie G Biesecker; Robert C Green
Journal:  N Engl J Med       Date:  2014-09-18       Impact factor: 91.245

4.  Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.

Authors:  Uri Ladabaum; Grace Wang; Jonathan Terdiman; Amie Blanco; Miriam Kuppermann; C Richard Boland; James Ford; Elena Elkin; Kathryn A Phillips
Journal:  Ann Intern Med       Date:  2011-07-19       Impact factor: 25.391

5.  Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population.

Authors:  Tuan A Dinh; Benjamin I Rosner; James C Atwood; C Richard Boland; Sapna Syngal; Hans F A Vasen; Stephen B Gruber; Randall W Burt
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-18

Review 6.  Next-generation sequencing in the clinic: are we ready?

Authors:  Leslie G Biesecker; Wylie Burke; Isaac Kohane; Sharon E Plon; Ron Zimmern
Journal:  Nat Rev Genet       Date:  2012-11       Impact factor: 53.242

7.  Availability and payer coverage of BRCA1/2 tests and gene panels.

Authors:  Elizabeth Clain; Julia R Trosman; Michael P Douglas; Christine B Weldon; Kathryn A Phillips
Journal:  Nat Biotechnol       Date:  2015-09       Impact factor: 54.908

8.  Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time.

Authors:  Jonathan S Berg; Muin J Khoury; James P Evans
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822

9.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.

Authors:  Robert C Green; Jonathan S Berg; Wayne W Grody; Sarah S Kalia; Bruce R Korf; Christa L Martin; Amy L McGuire; Robert L Nussbaum; Julianne M O'Daniel; Kelly E Ormond; Heidi L Rehm; Michael S Watson; Marc S Williams; Leslie G Biesecker
Journal:  Genet Med       Date:  2013-06-20       Impact factor: 8.822

10.  The arrival of genomic medicine to the clinic is only the beginning of the journey.

Authors:  James P Evans; Muin J Khoury
Journal:  Genet Med       Date:  2013-01-10       Impact factor: 8.822
View more
  6 in total

1.  Genomes reveal drastic and recurrent phenotypic divergence in firetip skipper butterflies (Hesperiidae: Pyrrhopyginae).

Authors:  Jing Zhang; Qian Cong; Jinhui Shen; Ernst Brockmann; Nick V Grishin
Journal:  Proc Biol Sci       Date:  2019-05-29       Impact factor: 5.349

2.  "What Goes Around Comes Around": Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine.

Authors:  Kathryn A Phillips; Michael P Douglas; Julia R Trosman; Deborah A Marshall
Journal:  Value Health       Date:  2017-01       Impact factor: 5.725

3.  Genomic architecture of fetal central nervous system anomalies using whole-genome sequencing.

Authors:  Ying Yang; Sheng Zhao; Guoqiang Sun; Fang Chen; Tongda Zhang; Jieping Song; Wenzhong Yang; Lin Wang; Nianji Zhan; Xiaohong Yang; Xia Zhu; Bin Rao; Zhenzhen Yin; Jing Zhou; Haisheng Yan; Yushan Huang; Jingyu Ye; Hui Huang; Chen Cheng; Shida Zhu; Jian Guo; Xun Xu; Xinlin Chen
Journal:  NPJ Genom Med       Date:  2022-05-13       Impact factor: 6.083

4.  Cancer Signature Investigation: ERBB2 (HER2)-Activating Mutation and Amplification-Positive Breast Carcinoma Mimicking Lung Primary.

Authors:  Jennifer Shih; Babar Bashir; Karen S Gustafson; Mark Andrake; Roland L Dunbrack; Lori J Goldstein; Yanis Boumber
Journal:  J Natl Compr Canc Netw       Date:  2015-08       Impact factor: 11.908

Review 5.  Cost-effectiveness analyses of genetic and genomic diagnostic tests.

Authors:  Katherine Payne; Sean P Gavan; Stuart J Wright; Alexander J Thompson
Journal:  Nat Rev Genet       Date:  2018-01-22       Impact factor: 53.242

6.  Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial.

Authors:  Kurt D Christensen; Jason L Vassy; Kathryn A Phillips; Carrie L Blout; Danielle R Azzariti; Christine Y Lu; Jill O Robinson; Kaitlyn Lee; Michael P Douglas; Jennifer M Yeh; Kalotina Machini; Natasha K Stout; Heidi L Rehm; Amy L McGuire; Robert C Green; Dmitry Dukhovny
Journal:  Genet Med       Date:  2018-03-22       Impact factor: 8.822
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.